Agenda

Displaying agenda in the event’s time zone (EDT, UTC -4)

MASTERCLASSES
Tuesday, September 24, 2024
CONFERENCE DAY 1
Wednesday, September 25, 2024
CONFERENCE DAY 2
Thursday, September 26, 2024

Registration and Networking Breakfast

Sense Making with AI in the Data Age

This Masterclass on Sense Making with AI offers a comprehensive exploration into leveraging artificial intelligence (AI) tools and methodologies to extract valuable insights, make informed decisions, and navigate complexity with clarity.

Developed by industry experts and thought leaders at the forefront of AI innovation, this Masterclass delves into the intersection of human cognition and machine intelligence. Participants will embark on a journey to understand how AI technologies can augment human capabilities in sense making, enabling them to unravel intricate patterns, detect trends, and glean actionable intelligence from data-rich environments.

Presented by Atacana Group

Refreshment Break

Synthesizing Primary Research Into Actionable Insights and Presentations

When it comes to gaining valuable insights from primary research, the challenge lies in synthesizing research data and drawing actionable insights to achieve your research objectives. The Molekule team will highlight the key considerations in designing primary research projects, synthesizing actionable insights from collected data, and articulating key findings into impactful and strategic presentations leading to a shared understanding.

Presented by Molekule

Networking Lunch

KITting and KIQing: Key Intelligence Topics and Questions- Asking the right questions will provide critical insight to your business

Learn the art and science behind crafting intelligent questions to uncover competitive insights on topics your business needs to stay ahead. During this hands-on exercise, you will design and refine questions to provide you with critical insights into key business questions. The interactive sessions will focus on question methodology, as well as consider potential sources, to help you cut through noise to get quality answers you need.

Presented by Lifescience Dynamics

Refreshment Break

Developing a Competitive Activity Framework to enhance organizational competitiveness

This workshop session, will give participants first-hand insights from a combined 30+ years of experience in delivering strategic and tactical workshop-style solutions, using an optimal blend of established CI frameworks alongside INOVIS' in-house proprietary methodologies.

Key to this session will be addressing business needs across the lifecycle, whereby participants will:

• Develop an in-depth understanding of how a diverse range of facilitated activities (Rapid Immersion, Threat Assessment and Competitor Simulations) can help deliver strategic and competitive insights within an organization
• Appreciate the importance of leveraging the outcomes of workshops to inform and direct decision making
Receive hands-on opportunities to apply learnings to a pharma case study in a learning environment
• Using business case studies, real-life experiences and validated theory, the INOVIS team will equip you with a number of go-to techniques that can be rapidly integrated into ongoing CI Practice, whether you’re a seasoned CI professional veteran, or newer to the field.

Presented by INOVIS

Refreshment Break

Learn how to ‘GameStorm’ and become familiar with the giants of competitive analysis models and frameworks

This workshop session, will give participants practical tools to design and run their own GameStorm to help move intelligence from the “So what?” to the “What next?” Over 90 minutes, Beth Elliott and Tony Nagle the Co-Founders of Dig Worldwide, will walk participants through and explain five key models that are invaluable for taking intelligence off-the-page and converting it into practical solutions. The giants of competitive analysis models and frameworks that will be discussed in outline are:
• VUCA –focusing specifically on the concept of the competitive “Why?”
• Scenario Planning
• Porters Five Forces Explained
• Porters Four Corners Explained
• Blindspot Analytical Framework

Presented by Dig Worldwide

Masterclasses Conclude

Registration & Networking Breakfast in Exhibition Hall

Chairperson’s Opening Remarks

Presented by Johnson & Johnson

Keynote: Inflation Reduction Act

Presented by PhRMA

Keynote: The Importance of Early Strategic Planning For Global Success

At its core, it is critical for pharma companies to keep their global commercial strategies in mind way ahead of commercial launch and integrate them into the R&D pipeline programs at every step.

In today’s complex healthcare ecosystem when the local regulatory authorities have numerous nuances, it is important to think beyond the regulatory and clinical trial perspective to improve a product’s probability of success in the global markets. Investing in product planning at very early stages has earned greater prominence in recent years. Through this session, we would like to share Molekule Consulting’s perspectives on the key factors to success to win the global markets.

Presented by Molekule Consulting

Networking & Refreshments in Exhibition Hall

Keynote: China and emerging markets as growing players in Pharma

Over recent years, China and emerging markets are playing a pivotal role in pharma driven by population size, specific regional dynamics and a multitude of other unique factors. Lifescience Dynamics in collaboration with Pfizer, will discuss some key trends in these markets with our analysis on where we think these markets are headed and the expected wider impact on the pharmaceutical industry.

Presented by Lifescience Dynamics and Pfizer

Keynote: Executive Level Boardroom Discussions

Presented by Abbott, AbbVie, BioMarin, Boehringer Ingelheim, Bristol Myers Squibb, Eli Lilly and Company, Johnson & Johnson, and Novartis Institutes for BioMedical Research

“Ask the Experts” Interactive Round Tables

(Explore and capture the power of participants’ Insights and experiences and exploration of these topics in this fun and informal environment in small groups.)
ROUNDTABLE 1
Creating a Cross-brand / Therapeutic Area CI Approach

Presented by Ferring

ROUNDTABLE 2
Precision in Disease Epidemiology Estimation: Mastering the Craft
Understanding the competitive landscape to predict launch time for upcoming assets.

Presented by Astellas

ROUNDTABLE 3
Delivering on KITs/KIQs vs. Objectives vs. Valued Contributions

Presented by MorphoSys

ROUNDTABLE 4
Leveraging CI Input & Analysis to Support Key Investment Decisions Across the Portfolio

Presented by Ipsen

ROUNDTABLE 5
TBD
ROUNDTABLE 6
TBD

Networking Luncheon

TRACK A

Is My AI Better than your AI?

There is no match for human curiosity and our ability to frame a key intelligence question (KIQ) that has the potential to allow one competitor to gain an edge over another.

Dig Worldwide’s talk will delve into why human intelligence will always persist as an essential component in the pursuit of competitive advantage. Tony Nagle and Beth Elliott Co-Founders of Dig Worldwide will present a primary intelligence practitioners view on:

• How is AI changing competitive intelligence?
• Why Human Intelligence will always be irreplaceable by AI?
• Their thoughts on a “Golden Mean”

Presented by Dig Worldwide

TRACK B

Help for Generative AI?! The Need for Proprietary Machine Learning When Summarizing News Alerts

Context counts. FENIX will show why training mainstream generative AI to an organization’s content lens is a critical success factor for creating the perception of value exchange.

The laborious task of creating concise, yet accurate news summaries is a perfect pairing for proprietary machine learning with mainstream generative AI. Don’t miss this session if you think CI should be conversing with your organization’s digital transformation stakeholders.

Presented by Fenix Group International

TRACK C

The State of the Biopharmaceutical Industry

As the biopharmaceutical industry is resiliently recovering from the challenges presented by the pandemic, the recovery has been already overshadowed by a range of macroeconomic and geopolitical factors.

The issues with supply-demand imbalance, inflation, market volatility and geopolitical tensions & conflicts continue to pose a degree of instability and challenges for economic recovery and growth prospects. Although the pharmaceutical industry is often viewed as recession-proof, it is not immune to future challenges. Ongoing drug pricing and reimbursement constraints, regulatory challenges, pressures to innovate, increased competition, as well as biotech funding instability will continue to test the biopharmaceutical industry in the coming years. In The State of the Biopharmaceutical Industry discussion, GlobalData will highlight what we see are the factors impacting business environment and key trends that are going to shape the biopharmaceutical industry in 2025 and beyond.

Presented by GlobalData Healthcare

TRACK A

The Evolution of CI Beyond the Brand

• Typical CI methodologies and planning window
• The forces at work in the healthcare marketplace (2030+)
• How to project the future marketplace of 2030+ with increased confidence

Presented by Ionis

TRACK B

The Appropriate use of AI Capabilities in Intelligence Groups: Striking the Right Balance Between AI/ML and CI Analysist Intuition

Presented by Lilly

TRACK C

Bending Without Breaking: Maintaining CI Excellence in a Season of Shrinking Budgets

When times are tough and budgets are tight, how do you flex and adapt to continue meeting stakeholder needs? Through a series of case studies and anecdotes, we’ll have a discussion on best practices for doing great work without stressing (too much) over funding.

Presented by Bristol Myers Squibb

TRACK A

AI-Enabled Continuous Monitoring: Enhancing Accuracy, Speed, and Strategic Insights

Discover how AI is revolutionizing the Continuous Monitoring process, by providing efficiencies through automation, exponential scale through rapid data processing, and surfacing insights for better decision making.

Presented by DataZymes

TRACK B

How Pharmas Use Generative AI for Competitive Intelligence Research

Pharmaceutical companies are some of the world's most technologically sophisticated enterprises, so it's not surprising they're at the vanguard of using generative AI. One early application is for mining market and competitive intelligence research. In this session, learn how leading drug development companies are employing GenAI to instantly derive insights from vetted credible sources to inform their product development, strategy and marketing decisions.

Presented by Northern Light

TRACK C

TBD

Networking & Refreshments in Exhibition Hall

TRACK A

Leveraging Intelligence to Inform Innovation Strategy

Research and analysis are the fundamental building blocks behind any innovation. They're essential for discovering unmet needs, learning what is or isn't already in the marketplace, gaining input on how to differentiate, and assessing the feasibility of a successful market entrance with an innovative product or service.

This session will share practical examples of how CI researchers/analysts help solve innovation team challenges around deciding where to invest and divest. and outline the key action steps to building a mutually beneficial relationship with Innovation teams to formulate effective Innovation strategies.

Objectives:
• Learn how research functions can best collaborate with an Innovation team
• Understand the kinds of insight most helpful for Innovation Labs
• Gain input on the integration of market, customer, and competitive research
• Acquire tips on how to foster engaging conversations that drive action to create strategies
• Apply best practices to support Innovation

Presented by Proactive Worldwide

TRACK B

CI and the Quest for the Single Source of Truth

The holy grail of the competitive intelligence world in pharma is access to a single source of truth. That one place - a dashboard or app - where you can go to get a clear, concise and accurate view of the market you are focused on.

What’s in your competitor’s pipeline? How are their trials progressing? Who is on the cusp of a merger that will increase their funding and how will this impact your business?
The thing is, an infallible single source of truth is not realistic. But how close can we get? In this session, Alex Bour will investigate the elements that would make up a single source of truth. He’ll address key questions that CI professionals need to ask as they embark on their quest and share guidance on what to look for in the answers.
– How do we conduct an effective business analysis of competitors in our space to spot key opportunities and threats?
– How can I find out how well our pipeline/ asset/ portfolio stacks up against the competition and where will the biggest competitive threats come from?
– What’s the most efficient way to stay on top of market events and catalysts, with industry-leading analyst perspective, implications, recommendations?

Presented by Norstella

TRACK C

Pharma CI in the Post-covid Era: Remote Workers, Offshore Operations, and the Integration of AI

Navigating from disjointed to optimized and seamless, and key learnings from pharma and consulting.

Presented by Deallus

TRACK A

Complexities in Working with Alliances

Presented by Legend Biotech

TRACK B

Increasing & Maximizing the Predictive Value of CI

Presented by Bristol Myers Squibb, CorMedix, Regeneron Pharmaceuticals, and Takeda Pharmaceuticals

TRACK C

How to be an Influencer of Strategic Decisions

Presented by Dewpoint Therapeutics, Eisai, Merck, Sanofi, and Vir Biotechnology

Cocktail Reception & Networking

Registration & Networking Breakfast in Exhibition Hall

TRACK A

Elevating CI as an Invaluable Partner for Brand Teams

Presented by AbbVie and Vertex

TRACK B

Macro Trends in Pharma and Biotech, and its Impact

Presented by AbbVie, BioMarin, InPhronesis and Janssen

TRACK C

How to antiCIpate competitive moves and deliver intelligence that aCtIvates

Presented by AbbVie, Intuitive, and Precision

TRACK A

How to Conduct Competitive Simulation Workshops Effectively and Efficiently: Lessons From Industry

Competitive simulation workshops are a powerful and diverse tool at the disposal of any CI function. In this presentation we will outline the basic elements that are key to any successful CI workshop. Using examples from our experiences at Servier, and in collaboration with our vendors Lifescience Dynamics, we will describe some recent successes we’ve had in conducting CI workshops with minimal notice but maximum impact and value.

Presented by Lifescience Dynamics and Servier

TRACK B

Generative AI for Competitive Intelligence

• Combining AI and human intelligence
• Case studies for insight gathering, summarization, and sentiment assignment
• Efficient information management for congress planning and beyond

Presented by LARVOL

TRACK C

TBD

Networking & Refreshments in Exhibition Hall

TRACK A

Are Disruptors Disrupting Your Strategy?

With the pace of innovations coming online, disruptors are fundamentally evolving and altering the competitive landscape and our ways of working. As the rate of change increases, pharma and healthcare companies must identify and deploy resilient strategies that not only withstand but, more importantly, capitalize on emerging opportunities. Join us as we examine some of the most poignant disruptors. We will also explore the tools and methods CI/MI practitioners use to better predict, adjust, and even enhance strategies to stay competitive.

Presented by Fletcher

TRACK B

Predicting Drug Approvals: A Neural Network Approach

Neural networks, when combined with Kognitic’s AI NLPs, can analyze vast clinical trial datasets to identify the patterns within. Kognitic has developed a revolutionary, deep-learning model to predict drug launch dates, factoring in dynamic factors, such as protocol changes. Discover how Kognitic empowers our partners' CI decision-making.

Presented by Kognitic

TRACK C

AI in CI

Presented by Prescient

“Ask the Experts” Interactive Round Tables

(Explore and capture the power of participants’ Insights and experiences and exploration of these topics in this fun and informal environment in small groups.)
ROUNDTABLE 1
Creating a Cross-brand / Therapeutic Area CI Approach

Presented by Ferring

ROUNDTABLE 2
Precision in Disease Epidemiology Estimation: Mastering the Craft
Understanding the competitive landscape to predict launch time for upcoming assets.

Presented by Astellas

ROUNDTABLE 3
Delivering on KITs/KIQs vs. Objectives vs. Valued Contributions

Presented by MorphoSys

ROUNDTABLE 4
Leveraging CI Input & Analysis to Support Key Investment Decisions Across the Portfolio

Presented by Ipsen

ROUNDTABLE 5
TBD
ROUNDTABLE 6
TBD

Networking Luncheon

Announcement of Raffle Prize Winners

Keynote: Generics & Biosimilars – Important Learnings from Real World Case Studies

This session highlights innovative approaches leveraged by generic and biosimilars to speed up market entry. Specifically, this presentation will enable you to

1. Advance your understanding of core regulatory routes, timelines and strategies
2. Understand core Gx/biosimilar product development and entry strategies
3. Learn from & set up a best-in-industry Gx/biosimilar regulatory intelligence (RI) and CI tracking program
The presentation will be supported by thought provoking real-world case studies to stress differences between theory vs actual approaches

Presented by INOVIS

Keynote: Futureproof Your Commercial Strategy with AI and Human Expertise to Overcome Uncertainty

• Learn how top pharma leaders navigate future scenarios with AI to avoid relying on guesswork that can produce costly missteps
• Explore how the combination of AI augmentation and human expertise is revolutionizing agile, cross-functional decision-making
• Work with future-looking insights from real-time data streams to sidestep hidden pitfalls to ensure long-term success

Presented by Atacana Group

Keynote: Hey FENIX, We Need Better CI Tools, Can Genny Help?

In 2023, FENIX unveiled two of its tech offerings - HeyFENIX and Project Genny.

In this session, FENIX will provide a new update from 2023 about our latest tools for enhancing CI workflows using natural language processing (NLP) and a contextually trained generative AI model. Importantly, both solutions match stakeholder behaviors and are simple to integrate. FENIX will focus on the stakeholder archetypes that benefit most and how our technology aligns with their business objectives. Finally, FENIX will demonstrate how these vital integrations can optimize asynchronous CI data retrieval and realize all efficiencies imaginable.

Presented by Fenix Group International

A Look Forward: Summary & Key Takeaways

Presented by Abbott, AbbVie, BioMarin, Boehringer Ingelheim, Bristol Myers Squibb, Eli Lilly and Company, Johnson & Johnson, and Novartis Institutes for BioMedical Research

Conference Concludes

“COVID-conscious” Guidelines Distributed in Detail On-site but Includes:

• Use of masks required: Please bring your own if preferred, but masks and hand sanitizer will also be provided.
• Greetings should be socially distanced: no handshakes, hugs, or kisses, etc.
• Meeting space will accommodate more spacing between attendees.
• The hotel experience will be entirely revamped with specific cleaning protocols.

error: Content is protected !!